S. Rapp

Efficacy of hepatitis B virus ribonuclease H inhibitors, a new class of replication antagonists, in FRG human liver chimeric mice

J. Sagartz, J. Tavis, R. Murelli, 2018, Antiviral research.

CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized mice

J. Sagartz, D. Tyrrell, L. Corey, 2020, Molecular therapy. Methods & clinical development.